Log in to your Inderes Free account to see all free content on this page.
Iconovo
1.14 SEK
+0.44 %
Less than 1K followers
ICO
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.44 %
-1.73 %
+0.44 %
-0.44 %
-20.07 %
-3.40 %
-96.51 %
-98.18 %
-96.52 %
Iconovo operates in the medical technology sector. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and coal, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and has its headquarters in Lund.
Read moreMarket cap
109.16M SEK
Turnover
34.56K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.5.
2026
General meeting '26
20.8.
2026
Interim report Q2'26
23.10.
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
QUARTERLY REPORT Q1 2026
Anders Månsson is appointed CEO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio